XCath
CompanyUnited States
XCath develops one asset, in human trials (Iris System in acute ischemic stroke). Mostly device; based in the United States.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 0
- Signals
Pipeline
1Remote robotic-assisted mechanical thrombectomy system.
Human trials, Device, acute ischemic stroke
Full company profiles: pipeline, trials, funding and people.